G1 Therapeutics

+$1.22 (+5.90%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GTHX and other stocks, options, and ETFs commission-free!

About GTHX

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib.

CEO
Jack Bailey
Employees
122
Headquarters
Research Triangle Park, North Carolina
Founded
2008

GTHX Key Statistics

Market Cap
925.86M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.10M
High Today
$22.00
Low Today
$20.56
Open Price
$20.72
Volume
790.68K
52 Week High
$37.07
52 Week Low
$10.81

GTHX Earnings

-$1.07
-$0.71
-$0.36
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$1.07 per share
Actual
-$0.65 per share
Replay Earnings Call

You May Also Like

WRK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure